atropine has been researched along with Learning Disabilities in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiramatsu, M; Kameyama, T; Mori, H; Murasawa, H | 1 |
| Han, YF; Pan, SY | 1 |
2 other study(ies) available for atropine and Learning Disabilities
| Article | Year |
|---|---|
Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist.
Topics: Acetylcholine; Animals; Atropine; Carbachol; Dynorphins; Extracellular Space; Learning Disabilities; Male; Memory Disorders; Muscarinic Agonists; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 1998 |
Learning deficits induced by 4 belladonna alkaloids are preferentially attenuated by tacrine.
Topics: Animals; Atropine; Avoidance Learning; Cholinesterase Inhibitors; Learning Disabilities; Male; Mice; Motor Activity; Muscarinic Antagonists; Retention, Psychology; Scopolamine; Scopolamine Derivatives; Solanaceous Alkaloids; Tacrine | 2000 |